載入...
Endocrine Therapy Initiation and Medical Oncologist Utilization Among Women Diagnosed with Ductal Carcinoma in Situ
BACKGROUND. Though randomized clinical trials have demonstrated a reduction in second breast events with endocrine therapy among women with ductal carcinoma in situ (DCIS), use of these therapies remains highly variable. The purpose of this study was to evaluate patient and treatment‐related factors...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423507/ https://ncbi.nlm.nih.gov/pubmed/28408621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0397 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|